PTC-209

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NamePTC-209
Drug Alias NamePTC-209
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolycomb complex protein BMI-1 inhibitors
TargetsPolycomb complex protein BMI-1
Therapy Area/IndicationsColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPtc Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesPtc Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A